Smith Hayes Advisers’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
$2.98M Sell
42,199
-2,248
-5% -$150K 0.61% 45
2015
Q4
$2.96M Buy
44,447
+492
+1% +$32.7K 0.62% 47
2015
Q3
$2.79M Sell
43,955
-232
-0.5% -$15.2K 0.6% 46
2015
Q2
$2.89M Buy
44,187
+586
+1% +$39.8K 0.57% 55
2015
Q1
$3.02M Sell
43,601
-252
-0.6% -$17.4K 0.6% 45
2014
Q4
$3.03M Sell
43,853
-197
-0.4% -$13.3K 0.63% 43
2014
Q3
$2.87M Sell
44,050
-2,585
-6% -$170K 0.67% 41
2014
Q2
$3.18M Buy
46,635
+1,074
+2% +$72K 0.75% 32
2014
Q1
$2.96M Buy
45,561
+688
+2% +$43.4K 0.73% 40
2013
Q4
$2.93M Sell
44,873
-1,316
-3% -$84.2K 0.96% 26
2013
Q3
$2.74M Buy
46,189
+2,554
+6% +$151K 1.05% 23
2013
Q2
$2.5M Buy
+43,635
New +$2.59M 1.04% 24

Other funds holding CL

Smith Hayes Advisers's CL Position: Q1 2016 in Review

Smith Hayes Advisers reduced its Colgate-Palmolive (CL) stake by 5.1% in Q1 2016, selling an estimated $150K and leaving 42,199 shares worth $2.98M. The position accounts for 0.61% of the portfolio, ranked #45.

Smith Hayes Advisers first reported a position in CL in Q2 2013 and has held it in 12 quarters since. The position peaked at $3.18M in Q2 2014. 1,262 funds tracked by Wall St. Rank hold CL as of Q1 2016.

  • Smith Hayes Advisers held 42,199 shares of Colgate-Palmolive worth $2.98M as of Q1 2016.
  • Smith Hayes Advisers sold 2,248 Colgate-Palmolive shares in Q1 2016, an estimated $150K.
  • Colgate-Palmolive made up 0.61% of Smith Hayes Advisers's portfolio in Q1 2016, its #45 holding.
  • Smith Hayes Advisers first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 12 quarters since.
  • Smith Hayes Advisers's Colgate-Palmolive position peaked at $3.18M in Q2 2014.
  • 1,262 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2016.

Based on Smith Hayes Advisers's 13F filing for Q1 2016, filed 16 May 2016.